Canada markets close in 56 minutes

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
27.89-2.07 (-6.91%)
As of 03:04PM EDT. Market open.
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
215,562
161,855
103,303
50,294
Selling General and Administrative
68,991
58,243
45,813
33,169
Total Operating Expenses
284,553
220,098
149,116
83,463
Operating Income or Loss
-284,553
-220,098
-149,116
-83,463
Total Other Income/Expenses Net
3,580
-5,393
-3,274
-46,433
Income Before Tax
-279,879
-225,334
-152,166
-128,344
Income Tax Expense
0
0
-24
45
Income from Continuing Operations
-279,879
-225,334
-152,142
-128,389
Net Income
-279,879
-225,334
-152,142
-128,389
Net Income available to common shareholders
-279,879
-225,334
-152,142
-128,389
Basic EPS
-
-1.65
-2.01
-1.01
Diluted EPS
-
-1.65
-2.01
-1.01
Basic Average Shares
-
136,577
73,643
127,124
Diluted Average Shares
-
136,577
73,643
127,124
EBITDA
-
-217,367
-148,719
-83,286